Vivimed Labs Reaffirms No Price Sensitive Information Regarding Securities Movement
Kanungo Financiers Limited, acting on behalf of Vivimed Labs Ltd, has addressed queries regarding recent significant movements in the company's securities price. The company asserted that it is not in possession of any material development or unpublished price sensitive information that could have influenced the trading volume or price movement of its securities.In response to the inquiries concerning fluctuations in its stock, the issuer stated that there was no proposed announcement or internal event that warranted a specific explanation regarding the recent market activity.
The company maintained that the observed volatility in the securities' pricing appeared to be purely driven by market forces.
Vivimed Labs Ltd affirmed its commitment to corporate governance and transparency. The company reiterated its dedication to providing timely disclosure of any material information as required under applicable laws.
VIVIMEDLAB Stock Price Movement
As of 1:50 PM, shares of Vivimed Labs Limited are shedding value in live trading, slipping 0.32% and currently registering at ₹6.19. The stock trades within an intraday range bounded between a low of ₹5.97 and a high of ₹6.25.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.